14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ADMS
Delisted

Adamas Pharmaceuticals Stock Price (Quote)

$8.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $8.22 $8.22 Friday, 27th May 2022 ADMS stock ended at $8.22. During the day the stock fluctuated 0% from a day low at $8.22 to a day high of $8.22.
90 days $8.22 $8.22
52 weeks $4.02 $8.25

Historical Adamas Pharmaceuticals prices

Date Open High Low Close Volume
Mar 24, 2020 $2.77 $2.83 $2.50 $2.58 200 399
Mar 23, 2020 $2.39 $2.66 $2.31 $2.58 195 261
Mar 20, 2020 $2.43 $2.54 $2.14 $2.41 334 308
Mar 19, 2020 $1.95 $2.48 $1.95 $2.42 302 542
Mar 18, 2020 $2.17 $2.28 $1.90 $1.99 291 547
Mar 17, 2020 $2.15 $2.40 $2.02 $2.32 308 816
Mar 16, 2020 $2.57 $2.69 $2.00 $2.16 455 059
Mar 13, 2020 $3.05 $3.10 $2.57 $2.70 442 159
Mar 12, 2020 $2.83 $3.08 $2.74 $2.86 389 189
Mar 11, 2020 $3.13 $3.18 $2.93 $3.05 358 156
Mar 10, 2020 $3.50 $3.56 $3.07 $3.24 390 095
Mar 09, 2020 $3.59 $3.67 $3.33 $3.35 353 102
Mar 06, 2020 $3.84 $3.96 $3.68 $3.89 332 730
Mar 05, 2020 $4.14 $4.22 $3.75 $3.83 528 008
Mar 04, 2020 $4.10 $4.37 $3.99 $4.20 1 493 155
Mar 03, 2020 $4.29 $4.43 $3.85 $3.98 642 813
Mar 02, 2020 $4.66 $4.66 $4.16 $4.28 410 732
Feb 28, 2020 $4.15 $4.62 $4.15 $4.56 358 038
Feb 27, 2020 $4.28 $4.64 $4.00 $4.37 499 007
Feb 26, 2020 $4.93 $5.50 $4.23 $4.43 557 292
Feb 25, 2020 $5.30 $5.40 $4.61 $4.77 385 542
Feb 24, 2020 $5.90 $5.95 $5.23 $5.25 810 431
Feb 21, 2020 $5.70 $5.83 $5.65 $5.79 295 112
Feb 20, 2020 $5.57 $5.77 $5.42 $5.69 210 238
Feb 19, 2020 $5.62 $5.75 $5.56 $5.59 314 819
Click to get the best stock tips daily for free!

About Adamas Pharmaceuticals

Adamas Pharmaceuticals Adamas Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company’s lead product candidate is the ADS-5102 that is in Phase 3 clinical development for the treatment of levodopa-induced dyskinesia, a movement disorder associated with Parkinson’s disease; and in a Phase 2 clinical study for the treatment of symptoms assoc... ADMS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT